C
84
2
LB
33
2
MDLZ
26
-2
PGR
44
2
TRIP
52
3
XEL
41
4
PNR
54
3
NEE
54
2
DHR
68
2
FOX
70
2
URI
49
3
LEN
21
-9
WMT
55
-4
THC
48
2
INTC
40
-3
ALLE
46
2
PG
43
-2
BWA
55
2
CMI
75
4
MTCH
70
11
C
84
2
LB
33
2
MDLZ
26
-2
PGR
44
2
TRIP
52
3
XEL
41
4
PNR
54
3
NEE
54
2
DHR
68
2
FOX
70
2
URI
49
3
LEN
21
-9
WMT
55
-4
THC
48
2
INTC
40
-3
ALLE
46
2
PG
43
-2
BWA
55
2
CMI
75
4
MTCH
70
11
Financhill
Back

The New York Times Co. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
85

NYT
The New York Times Co.

Last Price:
$70.62
Seasonality Move:
5.79%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
85
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $70.52. The Score for NYT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $70.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 78.76 Buy
Chaikin Money Flow: -703445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 68.34) Buy
Bollinger Bands (100): (55.87 - 64.19) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69 Buy
20-day SMA: 66.52 Buy
50-day SMA: 62.09 Buy
200-day SMA: 56.33 Buy
8-day EMA: 69.11 Buy
20-day EMA: 66.9 Buy
50-day EMA: 63.53 Buy
200-day EMA: 57.82 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):